129 related articles for article (PubMed ID: 26047365)
1. Molecular Recognition of PPARγ by Kinase Cdk5/p25: Insights from a Combination of Protein-Protein Docking and Adaptive Biasing Force Simulations.
Mottin M; Souza PC; Skaf MS
J Phys Chem B; 2015 Jul; 119(26):8330-9. PubMed ID: 26047365
[TBL] [Abstract][Full Text] [Related]
2. Exploring the mechanism of PPARγ phosphorylation mediated by CDK5.
Ribeiro Filho HV; Guerra JV; Cagliari R; Batista FAH; Le Maire A; Oliveira PSL; Figueira ACM
J Struct Biol; 2019 Sep; 207(3):317-326. PubMed ID: 31319193
[TBL] [Abstract][Full Text] [Related]
3. Insights into PPARγ Phosphorylation and Its Inhibition Mechanism.
Montanari R; Capelli D; Yamamoto K; Awaishima H; Nishikata K; Barendregt A; Heck AJR; Loiodice F; Altieri F; Paiardini A; Grottesi A; Pirone L; Pedone E; Peiretti F; Brunel JM; Itoh T; Pochetti G
J Med Chem; 2020 May; 63(9):4811-4823. PubMed ID: 32239932
[TBL] [Abstract][Full Text] [Related]
4. A novel non-agonist peroxisome proliferator-activated receptor γ (PPARγ) ligand UHC1 blocks PPARγ phosphorylation by cyclin-dependent kinase 5 (CDK5) and improves insulin sensitivity.
Choi SS; Kim ES; Koh M; Lee SJ; Lim D; Yang YR; Jang HJ; Seo KA; Min SH; Lee IH; Park SB; Suh PG; Choi JH
J Biol Chem; 2014 Sep; 289(38):26618-26629. PubMed ID: 25100724
[TBL] [Abstract][Full Text] [Related]
5. An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ.
Banks AS; McAllister FE; Camporez JP; Zushin PJ; Jurczak MJ; Laznik-Bogoslavski D; Shulman GI; Gygi SP; Spiegelman BM
Nature; 2015 Jan; 517(7534):391-5. PubMed ID: 25409143
[TBL] [Abstract][Full Text] [Related]
6. Development of an ELISA for High-Throughput Screening of Inhibitors of Cdk5-Mediated PPARγ Phosphorylation.
Prokoph N; Ormö M; O'Mahony G; Hogner A; McPheat J; Karlsson U; Holmberg Schiavone L; Liu J
Assay Drug Dev Technol; 2016 May; 14(4):261-72. PubMed ID: 27027223
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of PPARγ Affects the Collective Motions of the PPARγ-RXRα-DNA Complex.
Lemkul JA; Lewis SN; Bassaganya-Riera J; Bevan DR
PLoS One; 2015; 10(5):e0123984. PubMed ID: 25954810
[TBL] [Abstract][Full Text] [Related]
8. GQ-16, a novel peroxisome proliferator-activated receptor γ (PPARγ) ligand, promotes insulin sensitization without weight gain.
Amato AA; Rajagopalan S; Lin JZ; Carvalho BM; Figueira AC; Lu J; Ayers SD; Mottin M; Silveira RL; Souza PC; Mourão RH; Saad MJ; Togashi M; Simeoni LA; Abdalla DS; Skaf MS; Polikparpov I; Lima MC; Galdino SL; Brennan RG; Baxter JD; Pitta IR; Webb P; Phillips KJ; Neves FA
J Biol Chem; 2012 Aug; 287(33):28169-79. PubMed ID: 22584573
[TBL] [Abstract][Full Text] [Related]
9. Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.
Choi JH; Banks AS; Estall JL; Kajimura S; Boström P; Laznik D; Ruas JL; Chalmers MJ; Kamenecka TM; Blüher M; Griffin PR; Spiegelman BM
Nature; 2010 Jul; 466(7305):451-6. PubMed ID: 20651683
[TBL] [Abstract][Full Text] [Related]
10. Medium chain fatty acids are selective peroxisome proliferator activated receptor (PPAR) γ activators and pan-PPAR partial agonists.
Liberato MV; Nascimento AS; Ayers SD; Lin JZ; Cvoro A; Silveira RL; Martínez L; Souza PC; Saidemberg D; Deng T; Amato AA; Togashi M; Hsueh WA; Phillips K; Palma MS; Neves FA; Skaf MS; Webb P; Polikarpov I
PLoS One; 2012; 7(5):e36297. PubMed ID: 22649490
[TBL] [Abstract][Full Text] [Related]
11. Phloretin and phloridzin improve insulin sensitivity and enhance glucose uptake by subverting PPARγ/Cdk5 interaction in differentiated adipocytes.
Kumar S; Sinha K; Sharma R; Purohit R; Padwad Y
Exp Cell Res; 2019 Oct; 383(1):111480. PubMed ID: 31279631
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for the inhibitory effects of a novel reversible covalent ligand on PPARγ phosphorylation.
Jang JY; Kim H; Kim HJ; Suh SW; Park SB; Han BW
Sci Rep; 2019 Aug; 9(1):11168. PubMed ID: 31371757
[TBL] [Abstract][Full Text] [Related]
13. Transient expression, purification and characterisation of human full-length PPARγ2 in HEK293 cells.
Liu J; Ormö M; Nyström AC; Claesson J; Giordanetto F
Protein Expr Purif; 2013 Jun; 89(2):189-95. PubMed ID: 23562662
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for differential activities of enantiomeric PPARγ agonists: Binding of S35 to the alternate site.
Jang JY; Koh M; Bae H; An DR; Im HN; Kim HS; Yoon JY; Yoon HJ; Han BW; Park SB; Suh SW
Biochim Biophys Acta Proteins Proteom; 2017 Jun; 1865(6):674-681. PubMed ID: 28342850
[TBL] [Abstract][Full Text] [Related]
15. Identification of the First PPARα/γ Dual Agonist Able To Bind to Canonical and Alternative Sites of PPARγ and To Inhibit Its Cdk5-Mediated Phosphorylation.
Laghezza A; Piemontese L; Cerchia C; Montanari R; Capelli D; Giudici M; Crestani M; Tortorella P; Peiretti F; Pochetti G; Lavecchia A; Loiodice F
J Med Chem; 2018 Sep; 61(18):8282-8298. PubMed ID: 30199253
[TBL] [Abstract][Full Text] [Related]
16. CHARMM Force Field Parameterization of Peroxisome Proliferator-Activated Receptor γ Ligands.
Mottin M; Souza PC; Ricci CG; Skaf MS
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28025495
[TBL] [Abstract][Full Text] [Related]
17. Ocular expression of cyclin-dependent kinase 5 in patients with proliferative diabetic retinopathy.
Sano H; Namekata K; Niki M; Semba K; Murao F; Harada T; Mitamura Y
J Diabetes Investig; 2022 Apr; 13(4):628-637. PubMed ID: 34693664
[TBL] [Abstract][Full Text] [Related]
18. An in silico approach for the discovery of CDK5/p25 interaction inhibitors.
Zhang B; Corbel C; Guéritte F; Couturier C; Bach S; Tan VB
Biotechnol J; 2011 Jul; 6(7):871-81. PubMed ID: 21681969
[TBL] [Abstract][Full Text] [Related]
19. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
[TBL] [Abstract][Full Text] [Related]
20. Cyclin-Dependent Kinase 5 Inhibitor Butyrolactone I Elicits a Partial Agonist Activity of Peroxisome Proliferator-Activated Receptor γ.
Ahn S; Jang DM; Park SC; An S; Shin J; Han BW; Noh M
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32054125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
